(Q41269668)

28 September 2017

title

Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile (English)

1 reference

28 September 2017

1 reference

Duane WC

1

1 reference

28 September 2017

Hunninghake DB

2

1 reference

28 September 2017

Freeman ML

3

1 reference

28 September 2017

Pooler PA

4

1 reference

28 September 2017

Schlasner LA

5

1 reference

28 September 2017

Gebhard RL

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

28 September 2017

1 reference

28 September 2017

volume

8

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

1147-1150

1 reference

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Mechanisms of Lithogenic Bile Formation in American Indian Women with Cholesterol Gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Effect of ML-236B (compactin) on biliary excretion of bile salts and lipids, and on bile flow, in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Micro-determination of serum phosphate and phospholipids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism. Evidence for a distinct biliary precursor pool

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080531

7 January 2021

Identifiers

DOI

10.1002/HEP.1840080531

1 reference

28 September 2017

1 reference